Impact of Antiphospholipid Antibodies on Intracytoplasmic Sperm Injection Outcome
Main Article Content
Abstract
Introduction and Aim: The effect of antiphospholipid syndrome on pregnancy is extensively discussed but the debate is still ongoing. This debate increased when the association was examined after assisted reproductive techniques for infertility. The current work aimed to evaluate the influence of Antiphospholipid antibodies in patient undergo first cycle of intracytoplasmic sperm injection.
Subjects and Methods: The study comprised 130 of infertile females, who were scheduled for the first ICSI cycle. Before protocol selection, basal hormonal assay was performed and included FSH, LH, E2, prolactin and AMH. Plasma concentration of anti-phospholipids (APAs) was measured. Then, females were categorized into groups according to APAs (positive and negative groups). After ICSI, the clinical pregnancy was confirmed by presence the gestational sac or sac with positive pulsation. Ongoing pregnancy was recognized if the pregnancy continued after 12 weeks of the gestation and clinical miscarriage if pregnancy terminated before 12 weeks of gestation.
Results: All females were in their reproductive age (18- 40 years). Their fertility duration ranged between 1 and 7 years, and it was of primary type among 96 women. The long agonist protocol was used for 72 women and the antagonist protocol done for 58 women. The Antiphospholipid antibodies were positive among 27 females (20.8%), and there was no significant difference between APL positive and negative groups regarding pregnancy results (either chemical, clinical, incidence of abortion or ongoing pregnancy after 12 weeks) for all females. However, in women with positive clinical pregnancy, the rate of abortion was significantly increased in patients with APL- positive than negative females (66.7% vs 26.7%).
Conclusion: The presence of APA was associated with higher significant abortion rate after the first cycle of ICSI. Thus, screening for APA in women with infertility scheduled for assisted reproduction is recommended.
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
https://creativecommons.org/licenses/by-sa/4.0/
References
Leal Rato M, Bandeira M, Romão VC, Aguiar de Sousa D. Neurologic Manifestations of the Antiphospholipid Syndrome - an Update. Curr Neurol Neurosci Rep. 2021 Jun 14;21(8):41. doi: 10.1007/s11910-021-01124-z.
Lensen S, Shreeve N, Barnhart KT, Gibreel A, Ng EHY, Moffett A. In vitro fertilization add-ons for the endometrium: it doesn't add-up. Fertil Steril. 2019;112(6):987-993. doi: 10.1016/j.fertnstert. 2019.10.011.
Gerardi MC, Fernandes MA, Tincani A, Andreoli L. Obstetric Anti-phospholipid Syndrome: State of the Art. Curr Rheumatol Rep. 2018 Aug 13;20(10):59. doi: 10.1007/s11926-018-0772-y.
Sato S, Temmoku J, Fujita Y, Yashiro-Furuya M, Matsuoka N, Asano T, et al. Autoantibodies associated with neuropsychiatric systemic lupus erythematosus: the quest for symptom-specific biomarkers. Fukushima J Med Sci. 2020 22; 66(1):1-9. doi: 10.5387/fms.2020-02.
El Hasbani G, Khamashta M, Uthman I. Antiphospholipid syndrome and infertility. Lupus. 2020 Feb;29(2):105-117. doi: 10.1177/ 0961203319893763.
Hong YH, Kim SJ, Moon KY, Kim SK, Jee BC, Lee WD, Kim SH. Impact of presence of antiphospholipid antibodies on in vitro fertilization outcome. Obstet Gynecol Sci. 2018 May;61(3):359-366. doi: 10.5468/ogs.2018.61.3.359.
Zhong YP, Ying Y, Wu HT, Zhou CQ, Xu YW, Wang Q, Li J, Sheng XT, Li J. Impact of anticardiolipin antibody on the outcome of in vitro fertilization and embryo transfer. Am J Reprod Immunol. 2011 Dec;66(6):504-9. doi: 10.1111/j.1600-0897.2011.01058.x.
Brazdova A, Senechal H, Peltre G, Poncet P. Immune Aspects of Female Infertility. Int J Fertil Steril. 2016 Apr-Jun;10(1):1-10. doi: 10.22074/ijfs.2016.4762.
Gardner DK, Balaban B. Assessment of human embryo development using morphological criteria in an era of time-lapse, algorithms and 'OMICS': is looking good still important? Mol Hum Reprod. 2016 Oct;22(10):704-718. doi: 10.1093/molehr/gaw057.
Del Porto F, Ferrero S, Cifani N, Sesti G, Proietta M. Antiphospholipid antibodies and idiopathic infertility. Lupus. 2022 Mar;31(3):347-353. doi: 10.1177/09612033221076735.
Lee SR, Park EJ, Kim SH, Chae H, Kim CH, Kang BM. Influence of antiphospholipid antibodies on pregnancy outcome in women undergoing in vitro fertilization and embryo transfer. Am J Reprod Immunol. 2007;57(1):34-9. doi: 10.1111/j.1600-0897.2006. 00437.x.
Deeb H, Abdul Salam O, Shaaban V, Alkhatib A, Alhalabi N, Alhalabi M. Antiphospholipid antibodies levels and potential effects on in-vitro fertilization in a large cohort of infertile Syrian women. Ann Med Surg (Lond). 2021 Apr 18; 65:102301. doi: 10.1016/j.amsu.2021.102301.
Eldar-Geva T, Wood C, Lolatgis N, Rombauts L, Kovacs G, Fuscaldo J, Trounson AO. Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction. Hum Reprod. 1999;14(6):1461-6. doi: 10.1093/humrep/14.6.1461.
Abdullahi ZG, Abdul MA, Aminu SM, Musa BO, Amadu L, Jibril el-BM. Antiphospholipid antibodies among pregnant women with recurrent fetal wastage in a tertiary hospital in Northern Nigeria. Ann Afr Med. 2016 Jul-Sep;15(3):133-7. doi: 10.4103/1596-3519.188894.
Spinillo A, Bellingeri C, Cavagnoli C, Maggio I, Riceputi G, Ruspini B, Cesari S, Beneventi F. Maternal and foetal placental vascular malperfusion in pregnancies with anti-phospholipid antibodies. Rheumatology (Oxford). 2021 Mar 2;60(3):1148-1157. doi: 10.1093/rheumatology/keaa499.
Simopoulou M, Sfakianoudis K, Maziotis E, Grigoriadis S, Giannelou P, Rapani A, et al. The Impact of Autoantibodies on IVF Treatment and Outcome: A Systematic Review. Int J Mol Sci. 2019 Feb 19;20(4):892. doi: 10.3390/ijms20040892.